Skip to content

Staar Surgical STAA Additional Paid-In Capital

Additional Paid-In Capital at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
$295M+34.1%
IAR
Integra LifeSciencesIART
$1.34B+1.3%
ITG
Integer HoldingsITGR
$755.87M+0.2%
Glaukos logo
GlaukosGKOS
$1.62B+6.3%
HRO
HarrowHROW
$212.8M-5.7%
Bausch + Lomb logo
Bausch + LombBLCO
$8.58B+1.6%

Other financials

Income statement

See full
Revenue$93.5M+120%
Gross profit$68.9M+146%
Operating income$8.0M+114%
Net income$5.2M+110%
EPS (diluted)$0.10+109%

Balance sheet

See full
Cash & equivalents$131.9M-23.8%
Total debt$37.3M+1.7%
Total equity$352.4M+0.7%
Total assets$451.1M-1.4%

Cash flow

See full
Operating cash flow-$21.7M-278%
CapEx$443.0K-69.8%
Free cash flow-$22.1M-207%

Valuation

See full
Market cap$1.44B+47.4%
Enterprise value$1.35B+61.6%
P/S+1.5×

Profitability

See full
Gross margin76.9%+2.9pp
Operating margin-9.1%-3.5pp
Net margin-7.2%-3.0pp
FCF margin-19.6%+55.9pp

Returns & leverage

See full
Return on equity-6%-2.4pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.3×

Where this comes from

Reported directly by Staar Surgical in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Staar Surgical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Staar Surgical's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Staar Surgical's additional paid-in capital?
Staar Surgical (STAA) reported additional paid-in capital of $507.92M in Q1 2026.
How has Staar Surgical's additional paid-in capital changed year-over-year?
Staar Surgical's additional paid-in capital increased by 6.5% year-over-year, from $476.87M to $507.92M.
What is the long-term trend for Staar Surgical's additional paid-in capital?
Over 5 years (2020 to 2025), Staar Surgical's additional paid-in capital has grown at a 8.3% compound annual growth rate (CAGR), from $338.19M to $504.68M.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.